Investment Summary |
|
|---|---|
| Date | 2021-06-29 |
| Target | Causeway Technologies |
| Sector | Software |
| Investor(s) | Five Arrows |
| Deal Type | Growth Capital |
| Advisor(s) | Goldman Sachs (Financial) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| PE ASSETS | 24.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Five Arrows Principal Investments is a mid-cap investor in Western European companies. Five Arrows can invest across the capital structure (equity, equity-linked, mezzanine, convertible debt) and generally focused on primary or secondary buyouts, growth financings, and balance sheet restructurings. The Group does not have any sector preferences, but typically looks for businesses with high barriers to entry and predictable earnings. Five Arrows can commit €30 to €400 million per investment. Five Arrows is a unit of Rothschild Bank. The Group has offices in Paris, Luxembourg, and London.
| DEAL STATS | # |
|---|---|
| Overall | 43 of 58 |
| Sector: Software M&A | 7 of 11 |
| Type: Growth Capital M&A Deals | 5 of 6 |
| Country: United Kingdom M&A | 10 of 14 |
| Year: 2021 M&A | 5 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-29 |
Sygnature Discovery
Nottingham, United Kingdom Sygnature Discovery is a provider of outsourced drug discovery services to the UK and overseas biotech and pharma companies. Sygnature provides integrated drug discovery and preclinical services to clients across eight key therapeutic areas, including oncology, neuroscience, and inflammation & immunology, and has an outstanding track record of scientific excellence. Sygnature Discovery was founded in 2004 and is based in Nottingham, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-01 |
Stepping Stones Group
Lafayette, Colorado, United States Stepping Stones Group is a provider of therapeutic behavioral health services to a variety of public school districts and private learning centers. Stepping Stones Group is based in Lafayette, Colorado. |
Sell | - |